Ujjwal Neogi, Ph.D., is Associate Professor of Virology, Karolinska Institute and Adjunct Associate Professor, University of Missouri, US. Dr. Neogi obtained his doctoral degree from Department of Medicine Huddinge, Karolinska Institutet (KI) in 2013. He joined the Department of Laboratory Medicine as Assistant Professor in 2015 continued as Group Leader since 2018, where his research focuses on multi-omics system biology studies in infectious diseases to understand the mechanism of disease progression, immune-control and immune-aging.
Dr. Neogi has a longstanding research interest to understand the mechanisms of natural immune control in viral infection, focusing in particular on HIV-1 infected individuals called Elite Controllers (EC), who control HIV-infection spontaneously and more recently to other emerging and re-emerging viruses like SARS-CoV-2 and Crimean–Congo hemorrhagic fever (CCHF). His group aims to identify the components of the immune response required for natural immune protection that can be translated into the future development of functional HIV-cure including therapeutic vaccine strategies. In a systemic approach, his group applies high-throughput multi-omics technologies (e.g., transcriptomics, proteomics, metabolomics and microbiome), along with in vitro and ex vivo experimental methods to understand the microbiome-driven metabolic control of viruses as a novel therapeutic approach.
